Charles Schwab’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $718K | Buy |
981,372
+30,696
| +3% | +$22.4K | ﹤0.01% | 3004 |
|
|
2025
Q1 | $767K | Sell |
950,676
-26,181
| -3% | -$21.1K | ﹤0.01% | 2938 |
|
|
2024
Q4 | $1.35M | Buy |
976,857
+12,530
| +1% | +$17.3K | ﹤0.01% | 2808 |
|
|
2024
Q3 | $1M | Buy |
964,327
+116,217
| +14% | +$121K | ﹤0.01% | 2916 |
|
|
2024
Q2 | $1.47M | Buy |
848,110
+158,984
| +23% | +$275K | ﹤0.01% | 2796 |
|
|
2024
Q1 | $1.65M | Sell |
689,126
-78,571
| -10% | -$188K | ﹤0.01% | 2650 |
|
|
2023
Q4 | $2.56M | Buy |
767,697
+44,325
| +6% | +$148K | ﹤0.01% | 2537 |
|
|
2023
Q3 | $2.71M | Buy |
723,372
+193,449
| +37% | +$723K | ﹤0.01% | 2510 |
|
|
2023
Q2 | $2.26M | Buy |
529,923
+24,681
| +5% | +$105K | ﹤0.01% | 2507 |
|
|
2023
Q1 | $3.46M | Sell |
505,242
-1,547
| -0.3% | -$10.6K | ﹤0.01% | 2359 |
|
|
2022
Q4 | $4.01M | Buy |
506,789
+14,446
| +3% | +$114K | ﹤0.01% | 2323 |
|
|
2022
Q3 | $4.73M | Buy |
492,343
+16,346
| +3% | +$157K | ﹤0.01% | 2238 |
|
|
2022
Q2 | $3.45M | Buy |
475,997
+8,492
| +2% | +$61.5K | ﹤0.01% | 2353 |
|
|
2022
Q1 | $6.04M | Sell |
467,505
-7,732
| -2% | -$99.8K | ﹤0.01% | 2188 |
|
|
2021
Q4 | $7.59M | Buy |
475,237
+7,879
| +2% | +$126K | ﹤0.01% | 2142 |
|
|
2021
Q3 | $7.51M | Sell |
467,358
-8,320
| -2% | -$134K | ﹤0.01% | 2171 |
|
|
2021
Q2 | $6.58M | Buy |
475,678
+8,735
| +2% | +$121K | ﹤0.01% | 2215 |
|
|
2021
Q1 | $6.82M | Sell |
466,943
-40,230
| -8% | -$588K | ﹤0.01% | 2147 |
|
|
2020
Q4 | $8.82M | Sell |
507,173
-7,599
| -1% | -$132K | ﹤0.01% | 1935 |
|
|
2020
Q3 | $9.44M | Sell |
514,772
-103,718
| -17% | -$1.9M | ﹤0.01% | 1738 |
|
|
2020
Q2 | $11M | Sell |
618,490
-7,113
| -1% | -$127K | 0.01% | 1585 |
|
|
2020
Q1 | $10.1M | Sell |
625,603
-39,390
| -6% | -$639K | 0.01% | 1446 |
|
|
2019
Q4 | $12M | Buy |
664,993
+285,108
| +75% | +$5.13M | 0.01% | 1564 |
|
|
2019
Q3 | $7.7M | Buy |
379,885
+29,952
| +9% | +$607K | ﹤0.01% | 1755 |
|
|
2019
Q2 | $7.73M | Buy |
349,933
+30,584
| +10% | +$676K | ﹤0.01% | 1749 |
|
|
2019
Q1 | $4.36M | Buy |
319,349
+16,509
| +5% | +$225K | ﹤0.01% | 2039 |
|
|
2018
Q4 | $2.74M | Buy |
302,840
+229
| +0.1% | +$2.07K | ﹤0.01% | 2203 |
|
|
2018
Q3 | $4.99M | Buy |
302,611
+46,397
| +18% | +$766K | ﹤0.01% | 2041 |
|
|
2018
Q2 | $3.59M | Buy |
256,214
+45,144
| +21% | +$632K | ﹤0.01% | 2161 |
|
|
2018
Q1 | $2.33M | Buy |
211,070
+21,373
| +11% | +$236K | ﹤0.01% | 2271 |
|
|
2017
Q4 | $1.67M | Buy |
189,697
+32,016
| +20% | +$282K | ﹤0.01% | 2359 |
|
|
2017
Q3 | $2.11M | Sell |
157,681
-3,685
| -2% | -$49.2K | ﹤0.01% | 2265 |
|
|
2017
Q2 | $2.32M | Buy |
161,366
+27,064
| +20% | +$388K | ﹤0.01% | 2176 |
|
|
2017
Q1 | $2.84M | Buy |
134,302
+14,838
| +12% | +$314K | ﹤0.01% | 2047 |
|
|
2016
Q4 | $3.36M | Buy |
119,464
+5,631
| +5% | +$159K | ﹤0.01% | 1937 |
|
|
2016
Q3 | $3.05M | Buy |
113,833
+7,496
| +7% | +$201K | ﹤0.01% | 1920 |
|
|
2016
Q2 | $1.8M | Buy |
106,337
+55,566
| +109% | +$939K | ﹤0.01% | 2125 |
|
|
2016
Q1 | $1.08M | Buy |
50,771
+663
| +1% | +$14.1K | ﹤0.01% | 2311 |
|
|
2015
Q4 | $1.15M | Buy |
50,108
+845
| +2% | +$19.4K | ﹤0.01% | 2329 |
|
|
2015
Q3 | $988K | Buy |
49,263
+2,276
| +5% | +$45.6K | ﹤0.01% | 2385 |
|
|
2015
Q2 | $1.36M | Buy |
46,987
+27,711
| +144% | +$801K | ﹤0.01% | 2273 |
|
|
2015
Q1 | $590K | Buy |
19,276
+5,412
| +39% | +$166K | ﹤0.01% | 2573 |
|
|
2014
Q4 | $227K | Buy |
+13,864
| New | +$227K | ﹤0.01% | 2949 |
|